• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体和p185c-neu密度决定受体相互作用和酪氨酸激酶激活。

Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.

作者信息

Samanta A, LeVea C M, Dougall W C, Qian X, Greene M I

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104.

出版信息

Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1711-5. doi: 10.1073/pnas.91.5.1711.

DOI:10.1073/pnas.91.5.1711
PMID:7907421
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC43233/
Abstract

The neu protooncogene (also known as c-erbB2, NGL, and HER2) encodes a 185-kDa transmembrane glycoprotein with intrinsic tyrosine kinase activity that resembles the receptor for epidermal growth factor. The p185 gene and protein were originally identified in the brain and are thought to play a critical role in neurogenesis. Aberrant c-erbB2 protein overexpression also occurs in several human adenocarcinomas. A ligand for p185, neu-activating factor (NAF), specifically binds to neu receptor and increases the p185c-neu tyrosine phosphorylation in vitro and in vivo in a dose-dependent manner. We now show that NAF specifically binds to purified p185 expressed in baculovirus. Direct binding analysis showed that NAF binds with high affinity (Kd = 1.3 nM). We have investigated changes in the structure and association state of baculovirus-produced neu holoreceptor that are induced by ligand binding. In this study, we used sucrose gradients to show that purified p185c-neu exists mainly in the monomeric form at low concentrations, whereas at higher concentrations p185c-neu exists as dimers or multimers. At low concentrations, but in the presence of ligand, p185c-neu sediments as a dimeric or multimeric form. Monomer-oligomer interconversion is absolutely ligand dependent at low receptor concentrations. The high molecular weight form of the receptor is enzymatically more active, as a consequence of ligand-driven activation of the receptor kinase. Oncogenic p185neu receptors sediment predominantly as high molecular weight forms and have constitutively active kinases.

摘要

神经原癌基因(也称为c-erbB2、NGL和HER2)编码一种185 kDa的跨膜糖蛋白,具有内在酪氨酸激酶活性,类似于表皮生长因子受体。p185基因和蛋白最初在大脑中被鉴定出来,被认为在神经发生中起关键作用。异常的c-erbB2蛋白过表达也发生在几种人类腺癌中。p185的配体,神经激活因子(NAF),特异性结合神经受体,并在体外和体内以剂量依赖的方式增加p185c-neu酪氨酸磷酸化。我们现在表明,NAF特异性结合杆状病毒中表达的纯化p185。直接结合分析表明,NAF以高亲和力结合(Kd = 1.3 nM)。我们研究了配体结合诱导的杆状病毒产生的神经全受体的结构和缔合状态变化。在本研究中,我们使用蔗糖梯度表明,纯化的p185c-neu在低浓度下主要以单体形式存在,而在较高浓度下p185c-neu以二聚体或多聚体形式存在。在低浓度下,但在配体存在的情况下,p185c-neu以二聚体或多聚体形式沉降。在低受体浓度下,单体-寡聚体相互转化绝对依赖于配体。受体的高分子量形式在酶促作用下更具活性,这是配体驱动受体激酶激活的结果。致癌性p185neu受体主要以高分子量形式沉降,并具有组成型活性激酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/28f1b655ba86/pnas01127-0124-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/df36d848f8aa/pnas01127-0122-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/1e31658fd61d/pnas01127-0123-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/9fd838c4d5d5/pnas01127-0124-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/4b41d4c32891/pnas01127-0124-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/28f1b655ba86/pnas01127-0124-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/df36d848f8aa/pnas01127-0122-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/1e31658fd61d/pnas01127-0123-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/9fd838c4d5d5/pnas01127-0124-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/4b41d4c32891/pnas01127-0124-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b344/43233/28f1b655ba86/pnas01127-0124-c.jpg

相似文献

1
Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.配体和p185c-neu密度决定受体相互作用和酪氨酸激酶激活。
Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1711-5. doi: 10.1073/pnas.91.5.1711.
2
p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.p185c-neu与表皮生长因子受体结合形成由活化激酶组成的结构。
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1330-4. doi: 10.1073/pnas.89.4.1330.
3
Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.表皮生长因子诱导的磷酸化过程改变致癌性和细胞neu(NGL)基因产物。
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5389-93. doi: 10.1073/pnas.85.15.5389.
4
Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.p185c-neu与表皮生长因子(EGF)受体的协同相互作用导致啮齿动物成纤维细胞的转化。
Cell. 1989 Jul 28;58(2):287-92. doi: 10.1016/0092-8674(89)90843-x.
5
An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.一种致癌点突变使神经受体具有高亲和力配体结合能力。对位点异质性产生的影响。
J Biol Chem. 1992 Aug 25;267(24):17304-13.
6
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.p185是神经原癌基因的一种产物,是一种与酪氨酸激酶活性相关的类受体蛋白。
Mol Cell Biol. 1986 May;6(5):1729-40. doi: 10.1128/mcb.6.5.1729-1740.1986.
7
Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains.p185c-neu与表皮生长因子受体酪氨酸激酶的结构分析:激酶结构域的寡聚化
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6252-7. doi: 10.1073/pnas.93.13.6252.
8
Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.昆虫细胞表达的neu酪氨酸激酶正常形式与致癌形式的生化比较。
J Biol Chem. 1992 Jul 15;267(20):13851-6.
9
GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu.GM3含量调节表皮生长因子激活的p185c-neu水平,但不调节组成型激活的癌蛋白p185neu的水平。
Biochim Biophys Acta. 2003 Dec 30;1635(2-3):55-66. doi: 10.1016/j.bbalip.2003.10.006.
10
Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.表皮生长因子受体与野生型或激酶缺陷型Neu的异源二聚化:受体间激酶激活和转磷酸化的一种机制
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1500-4. doi: 10.1073/pnas.91.4.1500.

引用本文的文献

1
Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma.靶向HER2治疗尿路上皮癌的抗体药物偶联物:HER2阳性尿路上皮癌的潜在治疗方法。
Front Pharmacol. 2024 Mar 20;15:1326296. doi: 10.3389/fphar.2024.1326296. eCollection 2024.
2
Emergence of Mutation as a Biomarker and an Actionable Target in Solid Cancers.实体瘤中突变作为生物标志物和治疗靶点的出现。
Oncologist. 2019 Dec;24(12):e1303-e1314. doi: 10.1634/theoncologist.2018-0845. Epub 2019 Jul 10.
3
Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast Cancer.

本文引用的文献

1
Nerve growth factor revisited.再探神经生长因子
Trends Biochem Sci. 1993 Feb;18(2):48-52. doi: 10.1016/0968-0004(93)90052-o.
2
Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships.神经分化因子(NDF/heregulin)与Neu/HER-2的细胞类型特异性相互作用表明存在复杂的配体-受体关系。
EMBO J. 1993 Mar;12(3):961-71. doi: 10.1002/j.1460-2075.1993.tb05737.x.
3
Affinity labeling and partial purification of nerve growth factor receptors from rat pheochromocytoma and human melanoma cells.
基于曲妥珠单抗治疗HER2过表达乳腺癌的分子机制
ISRN Oncol. 2012;2012:428062. doi: 10.5402/2012/428062. Epub 2012 Nov 22.
4
Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.过表达 Her2 与 GEP100 的结合诱导自主侵袭活性,并为肺腺癌转移提供生物标志物。
PLoS One. 2011;6(9):e25301. doi: 10.1371/journal.pone.0025301. Epub 2011 Sep 22.
5
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305.生长因子诱导的他莫昔芬耐药与雌激素受体α的突变及其丝氨酸 305 磷酸化有关。
Breast Cancer Res Treat. 2010 Jan;119(1):71-85. doi: 10.1007/s10549-009-0334-0. Epub 2009 Feb 11.
6
Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.在此调节蛋白β通过HER2介导的AP-1激活促进MCF-7细胞中基质金属蛋白酶-7的表达。
Mol Cell Biochem. 2008 Nov;318(1-2):73-9. doi: 10.1007/s11010-008-9858-6. Epub 2008 Jul 4.
7
Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.表皮生长因子受体2(ErbB2)与转化生长因子β在诱导乳腺上皮细胞迁移和侵袭中的协同作用。
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1257-62. doi: 10.1073/pnas.0308090100. Epub 2004 Jan 22.
8
Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer.曲妥珠单抗,一种适用于HER2过表达转移性乳腺癌的一线单药治疗药物。
Breast Cancer Res. 2003;5(2):96-100. doi: 10.1186/bcr574. Epub 2003 Feb 3.
9
ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells.ErbB2和骨唾液蛋白作为转移性骨肉瘤细胞的标志物。
Br J Cancer. 2003 Feb 10;88(3):396-400. doi: 10.1038/sj.bjc.6600735.
10
ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.在p27单倍体不足的乳腺上皮细胞中,ErbB2/Neu诱导的、细胞周期蛋白D1依赖性转化加速,但在p27基因敲除细胞中受损。
Mol Cell Biol. 2002 Apr;22(7):2204-19. doi: 10.1128/MCB.22.7.2204-2219.2002.
大鼠嗜铬细胞瘤和人黑色素瘤细胞中神经生长因子受体的亲和标记及部分纯化
Proc Natl Acad Sci U S A. 1983 Nov;80(22):6819-23. doi: 10.1073/pnas.80.22.6819.
4
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.神经癌基因:一个与erb-B相关的基因,编码一种分子量为185,000的肿瘤抗原。
Nature. 1984;312(5994):513-6. doi: 10.1038/312513a0.
5
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.人类乳腺癌:HER-2/neu癌基因扩增与复发及生存的相关性。
Science. 1987 Jan 9;235(4785):177-82. doi: 10.1126/science.3798106.
6
Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding.表皮生长因子受体自身磷酸化及高亲和力结合的机制
Proc Natl Acad Sci U S A. 1987 Nov;84(22):7832-6. doi: 10.1073/pnas.84.22.7832.
7
Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation.表皮生长因子受体的自身磷酸化:分子间变构激活模型的证据
Biochemistry. 1987 Mar 10;26(5):1434-42. doi: 10.1021/bi00379a034.
8
Stage- and tissue-specific expression of the neu oncogene in rat development.神经癌基因在大鼠发育过程中的阶段和组织特异性表达。
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8498-501. doi: 10.1073/pnas.84.23.8498.
9
Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism.
J Biol Chem. 1988 Feb 15;263(5):2230-7.
10
Amplification of a novel v-erbB-related gene in a human mammary carcinoma.一种新型v-erbB相关基因在人乳腺癌中的扩增。
Science. 1985 Sep 6;229(4717):974-6. doi: 10.1126/science.2992089.